Domzalski David 4
4 · VYNE Therapeutics Inc. · Filed Oct 2, 2025
Insider Transaction Report
Form 4
Domzalski David
DirectorPRESIDENT AND CEO
Transactions
- Tax Payment
Common Stock
2025-09-30$0.34/sh−12,676$4,246→ 428,892 total
Footnotes (1)
- [F1]Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units.